# US 8,278,486 B2 · Process and intermediates for the preparation of N-acylated-4-aryl beta-amino acid derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,486 B2
- Document ID: US8278486B2
- Status: Granted
- Kind: B2
- Application number: 12/650,128
- Filed: 2009-12-30
- Published: 2010-11-04
- Granted: 2012-10-02
- Earliest claimed: 2008-12-31
- Assignees: Chiral Quest, Inc.
- Inventors: Shulin Wu; Bo Yu; Yejing Wang; Alain Delice; Jingyang Zhu
- Web page: https://patentgrep.com/patent/US8278486B2

## CPC

- C07D 487/04: Ortho-condensed systems
- C07B 53/00: Asymmetric syntheses
- C07C 269/06: by reactions not involving the formation of carbamate groups
- C07B 2200/07: Optical isomers
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A process for producing an enantiomerically enriched compound of Formula I: where the R-configuration, or S-configuration at the stereogenic center is marked with an *; by hydrogenating an enamide of formula III: in an organic solvent in the presence of a catalyst comprising a transition metal selected from rhodium or iridium, complexed to a chiral diphosphine ligand; Ar is optionally substituted phenyl; Z is OR1, SR1 or NR1R2; and P is R3, OR3 or NR3R4; R1 and R2 are selected from H, C1-8 alkyl, C5-12 cycloalkyl, aryl and aryl-C1-2-alkyl; or R1 and R2 together with the nitrogen atom form a C4-7-membered heterocyclic ring optionally fused with a 5- to 6-membered carbocyclic or heterocyclic ring; and R3 and R4 are selected from H, C1-8 alkyl, aryl, C5-12 cycloalkyl and aryl-C1-2-alkyl; or R3 and R4 together with the nitrogen atom form a C4-7-membered heterocyclic ring.

## Claims

### Claim 1

A process for producing an enantiomerically enriched compound having the structure of Formula I:
wherein the R-configuration, or S-configuration at the stereogenic center is marked with an *; which process comprises the step of hydrogenating an enamide compound having the structure of formula III:
in an organic solvent in the presence of a catalyst comprising a transition metal selected from the group consisting of rhodium and iridium, complexed to a chiral diphosphine ligand;
wherein Ar is phenyl which is unsubstituted or substituted with one to five substituents independently selected from the group consisting of halogen, trifluoromethyl, and trifluoromethoxy;
Z is OR1, SR1 or NR1R2; and P is R3, OR3 or NR3R4;
R1 and R2 are each independently selected from the group consisting of H, C1-8 alkyl, C5-12 cycloalkyl, aryl and aryl-C1-2-alkyl; or R1 and R2 together with the nitrogen atom to which they are attached form a C4-7-member heterocyclic ring system optionally containing an additional heteroatom selected from O, S, and N—C1-4-alkyl, said heterocyclic ring system being optionally fused with a 5- to 6-member saturated, unsaturated or aromatic carbocyclic ring system or a 5- to 6-member saturated, unsaturated or aromatic heterocyclic ring system containing one to two heteroatoms selected from O, S, and N—C1-4-alkyl, said fused ring system being unsubstituted or substituted with one to two substituents independently selected from the group consisting of hydroxy, amino, fluoro, C1-4 alkyl, C1-4 alkoxy and trifluoromethyl; and
R3 and R4 are each independently selected from the group consisting of H, C1-8 alkyl, aryl, C5-12 cycloalkyl and aryl-C1-2-alkyl; or R3 and R4 together with the nitrogen atom to which they are attached form a C4-7-member heterocyclic ring system optionally containing an additional heteroatom selected from O, S, and N—C1-4-alkyl.

### Claim 2 (depends on 1)

The process of claim 1 wherein the transition metal catalyst comprises [M(1,5-cyclooctadiene)2]X or [M(norbornadiene)2]X, wherein X is a noncoordinating anion selected from the group consisting of methanesulfonate, trifluoromethanesulfonate, tetrafluoroborate, hexafluorophosphate and hexafluoroantimonate; and M is rhodium or iridium.

### Claim 3 (depends on 1)

The process of claim 1, wherein said catalyst may be preformed or generated in situ, and is represented by the formula:
wherein X− is a non-coordinating anion selected from the group consisting of methanesulfonate trifluoromethanesulfonate, tetrafluoroborate, hexafluorophosphate and hexafluoroantimonate; L is a chelating diolefin selected from 1,5-cyclooctadiene or norbornadiene; M is rhodium or iridium; P is phosphorus; and each R is independently selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl and aryl.

### Claim 4 (depends on 1)

The process of claim 1 wherein Ar is 2,4,5-trifluorophenyl, or 2,5-difluorophenyl.

### Claim 5 (depends on 1)

The process of claim 1 wherein P is R3.

### Claim 6 (depends on 5)

The process of claim 5 wherein R3 is H, C1-8 alkyl or aryl.

### Claim 7 (depends on 1)

The process of claim 1 wherein P is OR3.

### Claim 8 (depends on 7)

The process of claim 7 wherein R3 is tert-butyl or benzyl.

### Claim 9 (depends on 1)

The process of claim 1 wherein Z is SR1 or NR1R2.

### Claim 10 (depends on 9)

The process of claim 9 wherein NR1R2 is a heterocycle with the structure of Formula VI:
wherein R5 is H, C1-4 alkyl or trifluoromethyl.

### Claim 11 (depends on 10)

The process of claim 10 wherein said R5 is trifluoromethyl.

### Claim 12 (depends on 1)

The process of claim 1 wherein said chiral diphosphine ligand is selected from the following compounds:
wherein each R is independently C1-8 alkyl, C3-8 cycloalkyl or aryl; and P is phosphorus.

### Claim 13 (depends on 12)

The process of claim 12, wherein said chiral diphosphine ligand is selected from the group consisting of TangPhos and DuanPhos.

### Claim 14

A process for producing an enantiomerically enriched compound having the structure of Formula I:
wherein the R-configuration, or S-configuration at the stereogenic center is marked with an *; which process comprises the steps of:
(i) reacting a compound having the structure of Formula V:
with an acylation reagent in the presence of an organic base in an organic solvent, to form an enamide compound having the structure of Formula III:
wherein said acylation reagent is selected from the group consisting of C2-8 alkyl-, aryl- and aryl-C1-2-alkyl-acyl chlorides, anhydrides and chloroformates;
and
(ii) hydrogenating said enamide compound in an organic solvent in the presence of a catalyst comprising a transition metal selected from the group consisting of rhodium and iridium, complexed to a chiral diphosphine ligand;
wherein Ar is phenyl which is unsubstituted or substituted with one to five substituents independently selected from the group consisting of halogen, trifluoromethyl, and trifluoromethoxy;
Z is OR1, SR1 or NR1R2; and P is R3, OR3 or NR3R4;
R1 and R2 are each independently selected from the group consisting of H, C1-8 alkyl, C5-12 cycloalkyl, aryl and aryl-C1-2-alkyl; or R1 and R2 together with the nitrogen atom to which they are attached form a C4-7-member heterocyclic ring system optionally containing an additional heteroatom selected from O, S, and N—C1-4-alkyl, said heterocyclic ring system being optionally fused with a 5- to 6-member saturated, unsaturated or aromatic carbocyclic ring system or a 5- to 6-member saturated, unsaturated or aromatic heterocyclic ring system containing one to two heteroatoms selected from O, S, and N—C1-4-alkyl, said fused ring system being unsubstituted or substituted with one to two substituents independently selected from the group consisting of hydroxy, amino, fluoro, C1-4 alkyl, C1-4 alkoxy and trifluoromethyl; and
R3 and R4 are each independently selected from the group consisting of H, C1-8 alkyl, aryl, C5-12 cycloalkyl and aryl-C1-2-alkyl; or R3 and R4 together with the nitrogen atom to which they are attached form a C4-7-member heterocyclic ring system optionally containing an additional heteroatom selected from O, S, and N—C1-4-alkyl.

### Claim 15 (depends on 14)

The process of claim 14, wherein said catalyst may be preformed or generated in situ, and is represented by the formula:
wherein X− is a non-coordinating anion selected from the group consisting of methanesulfonate trifluoromethanesulfonate, tetrafluoroborate, hexafluorophosphate and hexafluoroantimonate; L is a chelating diolefin selected from 1,5-cyclooctadiene or norbornadiene; M is rhodium or iridium; P is phosphorus; and each R is independently selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl and aryl.

### Claim 16 (depends on 14)

The process of claim 14 wherein said acylation reagent is acetyl chloride, acetic anhydride, tert-butoxycarbonyl anhydride or benzyl chloroformate.
